[Controlled study of the effect of silymarin on alcoholic liver disease].

A controlled trial on the use of Silymarin in patients with alcoholic liver disease was performed. Seventy two patients were admitted to the trial and randomly assigned to an experimental or controls group. Experimentals received 280 mg/day of Silymarin and controls an equal number of placebo tablet...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Bunout, Daniel, Hirsch, Sandra, Petermann, Marcus, de la Maza, María Pía, Silva, G, Kelly, Matt, Vizcarra Ugarte, German Alex, Iturriaga, H
Formato:	Artículo
Lenguaje:	inglés
Publicado:	1992
Materias:	Placebo Medicine Internal medicine Alcoholic liver disease Gastroenterology Ingestion Alcoholic hepatitis Alcohol Bilirubin Liver disease Albumin Randomized controlled trial Surgery Cirrhosis Pathology Chemistry Alternative medicine Biochemistry Double-Blind Method Female Humans Liver Diseases, Alcoholic blood Liver Diseases, Alcoholic drug therapy Liver Diseases, Alcoholic mortality Liver Function Tests Male Middle Aged Patient Compliance Silymarin adverse effects Silymarin therapeutic use Temperance Treatment Outcome Health Sciences Medicine Pathology and Forensic Medicine Alcohol Consumption and Health Effects Health Sciences Medicine Pulmonary and Respiratory Medicine Silymarin and Mushroom Poisoning Life Sciences Pharmacology, Toxicology and Pharmaceutics Pharmacology Drug-Induced Hepatotoxicity and Protection
Acceso en línea:	Ver en el sistema de origen Enlace permanente (DOI o Handle)
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

[Controlled study of the effect of silymarin on alcoholic liver disease].

Ejemplares similares